Purpose:: To evaluate the possibility of using peripheral-blood presurfactant protein B (Pro-SFTPB) for screening non-small cell lung cancer (NSCLC).
Methods:: A total of 873 healthy volunteers and 165 lung cancer patients hospitalized in the Fifth People's Hospital of Dalian were tested Pro-SFTPB once every half year from January 2014 to September 2015. The healthy volunteers were also conducted spiral computed tomography (CT) examination once every year.
Chin Med J (Engl)
February 2010
Background: IIIb-T(4) non-small cell lung cancer (NSCLC) is commonly considered a contraindication to surgery, although chemo-radiotherapy also achieves a poor survival rate. We reviewed our experience with T(4) NSCLC patients who underwent surgery to explore the indications and prognostic factors of surgical treatment of lung cancer invading the left atrium and great vessels.
Methods: We investigated a cohort of 105 patients, 79 men and 26 women, who underwent surgery from May 1996 to July 2008.
Objective: To explore the clinical manifestations and treatment of pulmonary sequestration.
Methods: Thirty-five patients with pulmonary sequestration confirmed by pathological studies were analyzed.
Results: Among these patients, 29 were of intralobar type and 6 of extralobar type.